4.4 Letter

COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report

Related references

Note: Only part of the references are listed.
Article Hematology

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report

Massimo Breccia et al.

Summary: Limited information is available on the impact of the COVID-19 pandemic on the management of chronic myeloid leukaemia (CML). A retrospective study in Italy showed that during the pandemic, a majority of CML patients were infected with SARS-CoV-2, some stopped TKI therapy, and 12 patients died from COVID-19, highlighting the need for enhanced protection and management of CML patients.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Oncology

Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain

Josep-Maria Ribera et al.

Summary: The study compared the characteristics and outcomes of adults with acute lymphoblastic leukemia (ALL) and COVID-19 infection in the first and second waves of the pandemic in Spain. The presence of comorbidities at COVID-19 infection was identified as the only prognostic factor for survival, highlighting the importance of vaccination priority for these patients.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)

Article Infectious Diseases

Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection

F. Cogliati Dezza et al.

Summary: This study evaluated determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection and found that older age, albumin level, tocilizumab, and corticosteroid treatment were independently associated with late viral clearance.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)

Article Oncology

The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population

Massimiliano Bonifacio et al.

Summary: Patients with chronic myeloid leukemia (CML) generally experience mild course of SARS-CoV-2 infection after exposure and it is safe to continue with tyrosine kinase inhibitors (TKIs) during the COVID-19 pandemic. Positive anti-SARS-CoV-2 serology in CML patients is more common in males and active workers.

CANCER MEDICINE (2021)

Article Oncology

COVID-19 and adult acute lymphoblastic leukemia: Presentation and management

Ayesha Butt et al.

HEMATOLOGY TRANSFUSION AND CELL THERAPY (2021)

Letter Hematology

COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia

Yinlian Wu et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Letter Oncology

Imatinib is not a potent anti-SARS-CoV-2 drug

Helong Zhao et al.

LEUKEMIA (2020)

Article Medicine, General & Internal

Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Robin Foa et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)